BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 12515770)

  • 1. Whither preventive medicine?
    Rapoport D
    CMAJ; 2003 Jan; 168(1):11; author reply 12. PubMed ID: 12515770
    [No Abstract]   [Full Text] [Related]  

  • 2. Testosterone replacement therapy: is it worth the risk?
    Zurlinden J
    Nurs Spectr (Wash D C); 1999 Jun; 9(12):15-6. PubMed ID: 10562231
    [No Abstract]   [Full Text] [Related]  

  • 3. Hormone therapy: a dangerous elixir?
    Pearson H
    Nature; 2004 Sep; 431(7008):500-1. PubMed ID: 15457228
    [No Abstract]   [Full Text] [Related]  

  • 4. Central serous chorioretinopathy associated with testosterone therapy.
    Ahad MA; Chua CN; Evans NM
    Eye (Lond); 2006 Apr; 20(4):503-5. PubMed ID: 15846380
    [No Abstract]   [Full Text] [Related]  

  • 5. Risks of testosterone replacement.
    Redmond G
    N Engl J Med; 2004 May; 350(19):2004-6; author reply 2004-6. PubMed ID: 15131838
    [No Abstract]   [Full Text] [Related]  

  • 6. Risks of testosterone replacement.
    Harris RM
    N Engl J Med; 2004 May; 350(19):2004-6; author reply 2004-6. PubMed ID: 15131837
    [No Abstract]   [Full Text] [Related]  

  • 7. Polycythemia in a physician secondary to self-administered growth hormone, testosterone, and dehydroepiandrosterone to prevent aging.
    Kwong YL; Lam CC
    J Am Geriatr Soc; 2004 Jun; 52(6):1031-2. PubMed ID: 15161484
    [No Abstract]   [Full Text] [Related]  

  • 8. Metastatic prostate cancer after orchiectomy, radiotherapy, and testosterone replacement in a patient with bilateral seminoma.
    Manassero F; Erba P; Mariani G; Mogorovich A; Giannarini G; Selli C
    J Androl; 2007; 28(1):10-2. PubMed ID: 16899814
    [No Abstract]   [Full Text] [Related]  

  • 9. Risks of testosterone replacement.
    Shames DA
    N Engl J Med; 2004 May; 350(19):2004-6; author reply 2004-6. PubMed ID: 15128905
    [No Abstract]   [Full Text] [Related]  

  • 10. Testosterone replacement in elderly men.
    Baum NH; Crespi CA
    Geriatrics; 2007 Sep; 62(9):15-8. PubMed ID: 17824721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extraprostatic complications of testosterone replacement therapy.
    Volpi R; Coiro V; Chiodera P; Saccani-Jotti G; Delsignore R
    J Endocrinol Invest; 2005; 28(11 Suppl Proceedings):75-7. PubMed ID: 16760630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone and ageing: what have we learned since the Institute of Medicine report and what lies ahead?
    Miner MM; Seftel AD
    Int J Clin Pract; 2007 Apr; 61(4):622-32. PubMed ID: 17343664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testosterone replacement.
    Tariman JD
    Adv Nurse Pract; 2007 May; 15(5):22. PubMed ID: 20000206
    [No Abstract]   [Full Text] [Related]  

  • 14. Should testosterone replacement be given to men with large prostates?
    Marks LS; Kaplan SA
    J Urol; 2009 Nov; 182(5):2109-11. PubMed ID: 19758636
    [No Abstract]   [Full Text] [Related]  

  • 15. Testosterone replacement therapy and prostate risks: where's the beef?
    Morgentaler A
    Can J Urol; 2006 Feb; 13 Suppl 1():40-3. PubMed ID: 16526980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The uses and misuses of testosterone therapy.
    Johns Hopkins Med Lett Health After 50; 2006 Aug; 18(6):3, 7. PubMed ID: 16921650
    [No Abstract]   [Full Text] [Related]  

  • 17. Re: Prostate cancer in men using testosterone supplementation. F. D. Gaylis, D. W. Lin, J. M. Ignatoff, C. L. Amling, R. F. Tutrone and D. J. Cosgrove.
    Morgentaler A; Rhoden EL; Barqawi AB; Crawford ED
    J Urol; 2006 Apr; 175(4):1572; author reply 1573-4. PubMed ID: 16516047
    [No Abstract]   [Full Text] [Related]  

  • 18. 54-year-old man with breast cancer after prolonged testosterone therapy.
    Sorscher S; Krause W
    Clin Adv Hematol Oncol; 2005 Jun; 3(6):475; discussion 476. PubMed ID: 16167025
    [No Abstract]   [Full Text] [Related]  

  • 19. Testosterone replacement therapy and the risk of prostate cancer: a perspective view.
    Barqawi AB; Crawford ED
    Int J Impot Res; 2005; 17(5):462-3. PubMed ID: 15889127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of demographic factors and biochemical characteristics on the prostate-specific antigen (PSA) response to testosterone replacement therapy.
    Rhoden EL; Morgentaler A
    Int J Impot Res; 2006; 18(2):201-5. PubMed ID: 16177827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.